AGPAT3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.131600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.780500E-02
Normal-vs-Stage2
5.860100E-02
Normal-vs-Stage3
4.974200E-02
Normal-vs-Stage4
3.334400E-02
Stage1-vs-Stage2
6.544800E-01
Stage1-vs-Stage3
1.925790E-01
Stage1-vs-Stage4
2.958600E-01
Stage2-vs-Stage3
2.470400E-01
Stage2-vs-Stage4
5.154400E-01
Stage3-vs-Stage4
6.932600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.911900E-02
Normal-vs-AfricanAmerican
9.085600E-01
Normal-vs-Asian
1.551200E-01
Caucasian-vs-AfricanAmerican
5.315700E-03
Caucasian-vs-Asian
5.529400E-01
AfricanAmerican-vs-Asian
1.233190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.520300E-02
Normal-vs-Female
5.899900E-02
Male-vs-Female
3.228600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.624500E-02
Normal-vs-Age(41-60Yrs)
1.407970E-01
Normal-vs-Age(61-80Yrs)
2.403900E-02
Normal-vs-Age(81-100Yrs)
1.508040E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.265200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.489200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.070200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.521000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.340600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.653800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.071500E-02
Normal-vs-Daily Drinker
1.901790E-02
Normal-vs-Weekly Drinker
8.262000E-02
Normal-vs-Occasional Drinker
9.532500E-02
Normal-vs-Social Drinker
1.731970E-01
Non Drinker-vs-Daily Drinker
3.061200E-01
Non Drinker-vs-Weekly Drinker
8.064400E-01
Non Drinker-vs-Occasional Drinker
5.304400E-01
Non Drinker-vs-Social Drinker
3.237800E-01
Daily Drinker-vs-Weekly Drinker
2.705400E-01
Daily Drinker-vs-Occasional Drinker
1.233020E-01
Daily Drinker-vs-Social Drinker
7.073800E-02
Weekly Drinker-vs-Occasional Drinker
7.548600E-01
Weekly Drinker-vs-Social Drinker
5.164400E-01
Occasional Drinker-vs-Social Drinker
6.947600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.801590E-01
Normal-vs-Grade 2
5.635900E-02
Normal-vs-Grade 3
6.485800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.660800E-01
Grade 1-vs-Grade 3
1.676230E-01
Grade 1-vs-Grade 4
1.801590E-01
Grade 2-vs-Grade 3
1.655980E-01
Grade 2-vs-Grade 4
5.635900E-02
Grade 3-vs-Grade 4
6.485800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.005540E-02
Normal-vs-NonDiabetic
4.894200E-02
Diabetic-vs-NonDiabetic
1.339170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.512600E-01
Normal-vs-NoPancreatitis
1.434200E-02
Pancreatitis-vs-NoPancreatitis
2.244800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.176400E-02
Normal-vs-N1
5.070000E-02
N0-vs-N1
9.967200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.848380E-01
Normal-vs-TP53-NonMutant
1.020020E-01
TP53-Mutant-vs-TP53-NonMutant
3.845400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
